Table 2 Expression of nuclear and cytoplasmic Ep-ICD and membranous EpEx in normal tissues and breast cancer histotypes
Tissue type | Number of tissues N | Nuclear Ep-ICD positivity n (%) | Cytoplasmic Ep-ICD positivity n (%) | Membranous EpEx positivity n (%) | Loss of membranous EpEx n (%) |
|---|---|---|---|---|---|
Normal | 45 | 11 (24% ) | 39 (87%) | 19 (42%) | 26 (58%) |
Breast cancer | 266 | 121 (46%) | 215 (81%) | 185 (70%) | 81 (30%) |
Histotypes * | Â | Â | Â | Â | Â |
DCIS | 61 (22.9%) | 30 (49%) | 48 (79%) | 47 (77%) | 14 (23%) |
IDC | 180 (67.6%) | 75 (42%) | 145 (81%) | 128 (71%) | 52 (29%) |
ILC | 15 | 10 | 12 | 3 | 12 |
IMC | 9 | 5 | 9 | 6 | 3 |